Click to copy
Click to copy

Agios Pharmaceuticals: 2Q Earnings Snapshot

August 1, 2019

CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $109.9 million in its second quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.87.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.73 per share.

The biopharmaceutical company posted revenue of $26.2 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $24.6 million.

Agios Pharmaceuticals shares have increased slightly more than 4% since the beginning of the year. The stock has decreased 44% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO

All contents © copyright 2019 The Associated Press. All rights reserved.